Meribank Biotech Co

Meribank Biotech Co Enterprise Value

The Enterprise Value (EV) of Meribank Biotech Co (4724.TWO) as of Oct 16, 2026 is 1.43 B TWD. In the previous year, Enterprise Value (EV) was 2.05 B TWD — a change of -30.30% (lower).

Enterprise Value

1.43 BTWD

YoY

-30.30%

Last updated:

Enterprise Value (EV) of Meribank Biotech Co is 2025 1.43 B TWD. Enterprise Value (EV) of Meribank Biotech Co was 2024 2.05 B TWD. It decreases by -30.30% lower compared to the previous year.

The Meribank Biotech Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
1.19 B TWD
Jan 1, 2020
1.25 B TWD
Jan 1, 2021
1.04 B TWD
Jan 1, 2022
1.11 B TWD
Jan 1, 2023
911.07 M TWD
Jan 1, 2024
2.05 B TWD
Jan 1, 2025
1.43 B TWD
The Meribank Biotech Co Enterprise Value history
YEAREnterprise ValueYoY
1.43 BTWD-30.30%
2.05 BTWD+125.48%
911.07 MTWD-18.25%
1.11 BTWD+6.83%
1.04 BTWD-16.48%
1.25 BTWD+4.92%
1.19 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Meribank Biotech Co Stock analysis

What does Meribank Biotech Co do? Meribank Biotech Co Ltd, listed on the Taiwan Stock Exchange with ticker 4724.TWO and ISIN TW0004724000, is headquartered in Taipei City, Taiwan. The company went public on June 16, 2023. Meribank Biotech focuses on the research and development of stem cell technologies, specifically providing cord blood (hematopoietic stem cells) storage and application services. It also offers storage and application services for placenta and umbilical cord (mesenchymal stem cells), as well as peripheral blood stem cell storage and application services. The company is involved in promoting stem cell transplantation applications and developing new stem cell processing technologies. Additionally, Meribank Biotech engages in the development of allogeneic umbilical cord mesenchymal stem cell manufacturing and therapeutic applications. The firm’s website is https://www.meribank.com.tw/. No further details on its sector, industry, or specific financial figures are provided in the available information. The company operates within the biotechnology sector, concentrating on stem cell-related services and technologies. Its IPO date marks its entry into the public market, with operations centered on the storage and application of various stem cell types for medical and therapeutic purposes. Meribank Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meribank Biotech Co stock

Enterprise Value (EV) of Meribank Biotech Co is 1.43 B TWD in 2025.

Enterprise Value (EV) of Meribank Biotech Co changed from 2.05 B TWD to 1.43 B TWD, representing a -30.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Meribank Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Meribank Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Meribank Biotech Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Meribank Biotech Co